Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.

We explored the possibility to target Ewing's sarcoma family of tumors (ESFT) by redirecting T cells. To this aim, we considered NKG2D-ligands (NKG2D-Ls) as possible target antigens. Detailed analysis of the expression of MICA, MICB, ULBP-1, -2, and -3 in fourteen ESFT cell lines revealed consi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manfred Lehner, Gabriel Götz, Julia Proff, Niels Schaft, Jan Dörrie, Florian Full, Armin Ensser, Yves A Muller, Adelheid Cerwenka, Hinrich Abken, Ornella Parolini, Peter F Ambros, Heinrich Kovar, Wolfgang Holter
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fe1b7ffa73194d2fa23042d04da80b5d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe1b7ffa73194d2fa23042d04da80b5d
record_format dspace
spelling oai:doaj.org-article:fe1b7ffa73194d2fa23042d04da80b5d2021-11-18T07:28:12ZRedirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.1932-620310.1371/journal.pone.0031210https://doaj.org/article/fe1b7ffa73194d2fa23042d04da80b5d2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22355347/?tool=EBIhttps://doaj.org/toc/1932-6203We explored the possibility to target Ewing's sarcoma family of tumors (ESFT) by redirecting T cells. To this aim, we considered NKG2D-ligands (NKG2D-Ls) as possible target antigens. Detailed analysis of the expression of MICA, MICB, ULBP-1, -2, and -3 in fourteen ESFT cell lines revealed consistent expression of at least one NKG2D-L. Thus, for redirecting T cells, we fused a CD3ζ/CD28-derived signaling domain to the ectodomain of NKG2D, however, opposite transmembrane orientation of this signaling domain and NKG2D required inverse orientation fusion of either of them. We hypothesized that the particularly located C-terminus of the NKG2D ectodomain should allow reengineering of the membrane anchoring from a native N-terminal to an artificial C-terminal linkage. Indeed, the resulting chimeric NKG2D receptor (chNKG2D) was functional and efficiently mediated ESFT cell death triggered by activated T cells. Notably, ESFT cells with even low NKG2D-L expression were killed by CD8(pos) and also CD4(pos) cells. Both, mRNA transfection and lentiviral transduction resulted in high level surface expression of chNKG2D. However, upon target-cell recognition receptor surface levels were maintained by tranfected RNA only during the first couple of hours after transfection. Later, target-cell contact resulted in strong and irreversible receptor down-modulation, whereas lentivirally mediated expression of chNKG2D remained constant under these conditions. Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT. A comparison of two different methods of gene transfer reveals strong differences in the susceptibility to ligand-induced receptor down-modulation with possible implications for the applicability of RNA transfection.Manfred LehnerGabriel GötzJulia ProffNiels SchaftJan DörrieFlorian FullArmin EnsserYves A MullerAdelheid CerwenkaHinrich AbkenOrnella ParoliniPeter F AmbrosHeinrich KovarWolfgang HolterPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 2, p e31210 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Manfred Lehner
Gabriel Götz
Julia Proff
Niels Schaft
Jan Dörrie
Florian Full
Armin Ensser
Yves A Muller
Adelheid Cerwenka
Hinrich Abken
Ornella Parolini
Peter F Ambros
Heinrich Kovar
Wolfgang Holter
Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
description We explored the possibility to target Ewing's sarcoma family of tumors (ESFT) by redirecting T cells. To this aim, we considered NKG2D-ligands (NKG2D-Ls) as possible target antigens. Detailed analysis of the expression of MICA, MICB, ULBP-1, -2, and -3 in fourteen ESFT cell lines revealed consistent expression of at least one NKG2D-L. Thus, for redirecting T cells, we fused a CD3ζ/CD28-derived signaling domain to the ectodomain of NKG2D, however, opposite transmembrane orientation of this signaling domain and NKG2D required inverse orientation fusion of either of them. We hypothesized that the particularly located C-terminus of the NKG2D ectodomain should allow reengineering of the membrane anchoring from a native N-terminal to an artificial C-terminal linkage. Indeed, the resulting chimeric NKG2D receptor (chNKG2D) was functional and efficiently mediated ESFT cell death triggered by activated T cells. Notably, ESFT cells with even low NKG2D-L expression were killed by CD8(pos) and also CD4(pos) cells. Both, mRNA transfection and lentiviral transduction resulted in high level surface expression of chNKG2D. However, upon target-cell recognition receptor surface levels were maintained by tranfected RNA only during the first couple of hours after transfection. Later, target-cell contact resulted in strong and irreversible receptor down-modulation, whereas lentivirally mediated expression of chNKG2D remained constant under these conditions. Together, our study defines NKG2D-Ls as targets for a CAR-mediated T cell based immunotherapy of ESFT. A comparison of two different methods of gene transfer reveals strong differences in the susceptibility to ligand-induced receptor down-modulation with possible implications for the applicability of RNA transfection.
format article
author Manfred Lehner
Gabriel Götz
Julia Proff
Niels Schaft
Jan Dörrie
Florian Full
Armin Ensser
Yves A Muller
Adelheid Cerwenka
Hinrich Abken
Ornella Parolini
Peter F Ambros
Heinrich Kovar
Wolfgang Holter
author_facet Manfred Lehner
Gabriel Götz
Julia Proff
Niels Schaft
Jan Dörrie
Florian Full
Armin Ensser
Yves A Muller
Adelheid Cerwenka
Hinrich Abken
Ornella Parolini
Peter F Ambros
Heinrich Kovar
Wolfgang Holter
author_sort Manfred Lehner
title Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
title_short Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
title_full Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
title_fullStr Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
title_full_unstemmed Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.
title_sort redirecting t cells to ewing's sarcoma family of tumors by a chimeric nkg2d receptor expressed by lentiviral transduction or mrna transfection.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/fe1b7ffa73194d2fa23042d04da80b5d
work_keys_str_mv AT manfredlehner redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT gabrielgotz redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT juliaproff redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT nielsschaft redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT jandorrie redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT florianfull redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT arminensser redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT yvesamuller redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT adelheidcerwenka redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT hinrichabken redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT ornellaparolini redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT peterfambros redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT heinrichkovar redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
AT wolfgangholter redirectingtcellstoewingssarcomafamilyoftumorsbyachimericnkg2dreceptorexpressedbylentiviraltransductionormrnatransfection
_version_ 1718423450260865024